Implantica reported a mixed financial performance for Q4 2024, with a 30% year-over-year decrease in quarterly revenue to €442,000, while full-year net sales rose by 38% to €1.9 million. The company's ...

Main Capital Partners returned (2.8)% net, bringing its year-to- date return to 8.2%. Click here to read the full fund letter ...

Morningstar this week announced the retirement of its Office platform product for advisors and a partnership with SS&C Black ...

Boost your SBI Clerk 2025 Prelims preparation with important topics and questions from Quantitative Aptitude Reasoning and ...